dr. plimack on a phase ib study of pembrolizumab in bladder cancer
Published 9 years ago • 220 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
1:18
dr. plimack on combo of pembrolizumab/epacodostat in bladder cancer
-
1:09
dr. plimack on frontline pembrolizumab for urothelial carcinoma
-
0:51
dr. elizabeth plimack on ipilimumab and pd-l1 inhibitors in the treatment of bladder cancer
-
1:18
dr. plimack on keynote-045 trial for pembrolizumab in urothelial carcinoma
-
1:36
pembrolizumab in urothelial cancer
-
1:04
dr. plimack on immunotherapy combinations in bladder cancer
-
1:00
dr. plimack on the growth of immunotherapy in bladder cancer
-
0:47
dr. plimack on the challenges with available immunotherapies for bladder cancer
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
1:35
dr. plimack on choosing a checkpoint inhibitor in bladder cancer
-
0:49
dr. elizabeth plimack on immunotherapy potential in bladder cancer
-
2:22
keynote-057: extended follow-up of pembrolizumab in bladder cancer
-
1:16
dr. plimack discusses a phase i trial analyzing mtor resistance in rcc
-
0:51
impact of the keynote-045 study comparing pembrolizumab and chemotherapy in bladder cancer
-
1:08
incorporating immunotherapy in the frontline treatment of patients with bladder cancer
-
1:09:47
evidence and insights on innovative treatment for bladder cancer
-
1:14
dr. plimack on second-line checkpoint inhibitors in bladder cancer
-
1:05
dr. jean hoffman-censits on the results of a phase ii trial studying atezolizumab in bladder cancer
-
3:52
expert comment: the javelin bladder 100 study | elizabeth plimack